Empowering investors with access to the best research, experts and opportunities.
Investing in biotech has become an increasingly attractive proposition for venture capitalists, but the sector can be hard to navigate – so we’ve enlisted one of Australia’s foremost experts in the field to share his thoughts for those in, or considering buying into, the sector.
Central banks around the world are embarking on a frenzy of rate hikes as they try to rein in inflation. The IMF says 75 central banks have raised interest rates in the past year, moving almost four times each on average – including Canada, which last Wednesday surprised global markets with a 100 basis-point increase, the largest by any G7 economy since 1998.
The global market for SaaS (software as a service) has been forecast to hit A$1 trillion in the next six years – and a number of Australian businesses are well-positioned to ride the wave.
With Ukraine and Russia producing 80% of global exports of sunflower seed oil, supplies have dwindled in recent months, leading to a cooking oil shortage and supermarket restrictions throughout Europe – but one German pub has found a solution.
Australian health and wellness brands company Wellnex Life will bring registered medicinal cannabis and hemp-based products to domestic and international markets, via a newly formed joint venture with OneLife Botanicals.
The US Food and Drug Administration has granted ‘orphan drug designation’ to PTX-100 for the treatment of peripheral T-cell lymphomas, paving the way for Prescient Therapeutics to lock in years of market exclusivity.
Australian share markets lost $74 billion in February when Russia invaded Ukraine, leaving many strong companies lost or forgotten in the flurry of the sell-off.
Australia’s labour shortage is becoming a real crisis. Businesses are struggling to fill 300,000 jobs, says the National Skills Commission, while the ABS puts combined private and public sector vacancies at 480,000 – 111% higher than in February 2020, prior to the pandemic.
No fewer than 374 ‘cash burners’ and 180 ‘zombies’ can be found lurking on the ASX, a former Thorney Investment Group fund manager has revealed – representing a significant opportunity for investors.
It’s the ATM coin trick that an increasing number of young Australians are using to create profits out of thin air – but not everyone is caught up in the magic of the new ‘coin noodling’ craze.
A nationwide scheme created to help small businesses recover from the impacts of the coronavirus crisis has come to an end at a rather inopportune time – just days before a fresh surge in COVID cases around the country.
By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.